drugset / Trial / NCT05860153

Intermittent Levetricetam in Treatment of Febrile Convulsions

NCT05860153

Unknown 100 enrolled Assiut University
RandomizedParallel-groupOpen-labelScreening

Summary

The American Academy of Pediatrics (AAP) in 2011 published a clinical practice guideline defining a febrile seizure as "a seizure accompanied by fever (temperature ≥ 100.4°F or 38°C by any method), without central nervous system infection, that occurs in infants and children 6 through 60 months of age." Febrile seizures are further classified as simple (generalized in onset, last less than 15 minutes, and do not occur more than once in 24 hours.) or complex (FS duration longer than 15 min, repeated convulsions within the same day, and focal seizure activity or focal findings during the postictal period.).

Timeline

Start
2023-06-01
Primary completion
2024-01-01
Completion
2024-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule 0.3 mg/kg Oral
Subject Levetiracetam Other / unclassified 15 mg/kg Oral
Subject Levetiracetam Other / unclassified 20 mg/kg Oral